ADUS Addus HomeCare 2026 stock outlook: how personal care economics work, why the acquisition engine and free cash flow matter, where Medicaid rate-setting and caregiver wages squeeze margins, peer comparison and US tax scenarios.
MMS (Maximus) 2026 stock outlook. How the company runs Medicaid, Medicare and other public benefit programs under long government contracts, why renewal rates stay high, what happens after the Medicaid redetermination bump, and the political risks behind its low multiple.
Acadia Healthcare (NASDAQ: ACHC) stock outlook 2026. A balanced, qualitative look at the largest US behavioral health bed operator's expansion and joint-venture strategy, Medicaid exposure, and DOJ scrutiny and litigation risk around admissions practices.
A practical 2026 guide to the Medicaid Asset Protection Trust: what a MAPT is, the five-year look-back and transfer penalty, income-only design, keeping the right to live in your home, preserving step-up in basis, and how a MAPT compares with gifting, an ILIT, and a Medicaid-compliant annuity.
A practical breakdown of long-term care insurance cost in the US market. How age, health underwriting, gender, benefit design, and inflation protection drive premiums, how traditional standalone compares to hybrid life and LTC policies, plus taxes, Medicaid, and how to choose.
UHS (Universal Health Services) 2026 stock outlook. A deep qualitative look at its two engines — acute-care hospitals and a very large behavioral-health franchise — plus the secular mental-health tailwind, labor and reimbursement pressure, regulatory and litigation risk, and the Miller family's long buyback record.
How a special needs trust (SNT) protects SSI and Medicaid eligibility while supplementing a disabled beneficiary's life. First-party (d4A) vs third-party vs pooled trusts, the Medicaid payback rule, ABLE accounts, choosing a trustee, attorney costs, and the costly mistakes to avoid in 2026.
A deep look at Molina Healthcare (MOH) stock heading into 2026: the Medicaid margin cycle, medical cost ratio dynamics, the Florida and Illinois contract stories, the MAPD and Marketplace pullback, competitor positioning versus Centene and UnitedHealth, and what Korean investors need to know about capital gains tax on a no-dividend stock.
CNC Centene stock outlook 2026: Medicaid redetermination enrollment shock, Ambetter ACA marketplace growth, Wellcare Medicare expansion, MLR normalization path, state contract risk, and scenario analysis for US managed care investors.
Most families learn about Medicaid's 5-year lookback rule the hard way — after a gift or transfer has already triggered a penalty period. Here's how the rules work under 42 U.S.C. §1396p, what common mistakes cost families months of uncovered care, and which legal strategies still hold up in 2026.